BRCA1 Gene Mutation: Clinical Trials

9 trials for BRCA1 Gene Mutation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 active not recruiting, 1 recruiting, 1 suspended. 9 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable9Completed 3, Active not recruiting 2, Recruiting 1, Suspended 1, Unknown 1, Withdrawn 1

Follow BRCA1 Gene Mutation: new trials by email Literature Review of BRCA1 Gene Mutation trials Research Report on BRCA1 Gene Mutation

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
Risk-reducing salpingectomy with delayed oophorectomy, Risk-reducing salpingo-oophorectomy - BRCA1 Gene Mutation, BRCA2 Gene Mutation
Not applicableRecruitingUniversity Medical Center Nijmegen30002020-03-012026-04-06
Usefulness of Video-Based Intervention in Helping Participants Encourage Their Families to Get Tested for BRCA Gene Mutations
Informational Intervention, Survey Administration - BRCA1 Gene Mutation, BRCA2 Gene Mutation
Not applicableCompletedOhio State University Comprehensive Cancer Center582018-04-052026-02-10
Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible)
Educational Intervention, Genetic Counseling, Laboratory Biomarker Analysis - BARD1 Gene Mutation, BRCA1 Gene Mutation
Not applicableSuspendedM.D. Anderson Cancer Center52002017-04-182026-08-26
Pancreatic Cancer Screening of High-Risk Individuals in Arkansas
Pancreatic Cancer Screening Pathway 1, Pancreatic Cancer Screening Pathway 2 - Pancreatic Neoplasms, Peutz-Jegher's Syndrome
Not applicableWithdrawnUniversity of Arkansas2015-11-012019-07-29
The Link Between BRCA Mutation and Endothelial Function
Endothelial function assessment, Cardiovascular biomarkers, Endothelial cells - BRCA1 Gene Mutation, BRCA2 Gene Mutation
Not applicableUnknownRabin Medical Center822015-02-012017-07-18
Early Salpingectomy (Tubectomy) With Delayed Oophorectomy in BRCA1/2 Gene Mutation Carriers
Salpingectomy with delayed oophorectomy, Risk-reducing salpingo-oophorectomy - BRCA1 Gene Mutation, BRCA2 Gene Mutation
Not applicableActive not recruitingUniversity Medical Center Nijmegen5102015-01-012024-12-05
A Nutritional Intervention to Decrease Breast Density Among Female BRCA (BReast CAncer Susceptibility Gene) Carriers
DIM-Avail 100mg - BRCA1 Gene Mutation, BRCA2 Gene Mutation
Not applicableCompletedRabin Medical Center232014-11-112020-11-12
Energy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family Members
Dietary Intervention, Internet-Based Intervention, Laboratory Biomarker Analysis - Body Mass Index 25 or Greater, BRCA1 Gene Mutation
Not applicableActive not recruitingM.D. Anderson Cancer Center3372014-09-172026-09-16
Pilot Study of Curcumin for Women With Obesity and High Risk for Breast Cancer
curcumin, Biomarker analysis, Assessment of Dietary Intake - Atypical Ductal Breast Hyperplasia, BRCA1 Gene Mutation
Not applicableCompletedOhio State University Comprehensive Cancer Center292013-06-012019-08-30

Narrower conditions

Breast Neoplasms (3)  ·  Ovarian Neoplasms (3)  ·  Colorectal Neoplasms, Hereditary Nonpolyposis (2)  ·  Ataxia Telangiectasia (1)  ·  Breast Carcinoma In Situ (1)  ·  Carcinoma, Intraductal, Noninfiltrating (1)  ·  Fatigue (1)  ·  Hereditary pancreatitis (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Melanoma, Cutaneous Malignant (1)  ·  Overweight (1)  ·  Pancreatic Neoplasms (1)  ·  Peutz-Jeghers Syndrome (1)  ·  Triple Negative Breast Neoplasms (1)

Broader conditions

Neoplasms (7)  ·  Neoplasms by Site (7)  ·  Skin Diseases (5)  ·  Skin and Connective Tissue Diseases (5)  ·  Breast Diseases (4)  ·  Endocrine Gland Neoplasms (4)  ·  Endocrine System Diseases (4)  ·  Adnexal Diseases (3)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Genital Diseases (3)  ·  Genital Diseases, Female (3)  ·  Genital Neoplasms, Female (3)  ·  Gonadal Disorders (3)  ·  Neoplasms by Histologic Type (3)

Interventions

3,3'-diindolylmethane (1)  ·  Curcumin (1)  ·  Diet Therapy (1)  ·  Early Intervention, Educational (1)  ·  Educational Status (1)  ·  Genetic Counseling (1)  ·  Methods (1)  ·  Salpingectomy (1)  ·  Surveys and Questionnaires (1)

Sponsors

M.D. Anderson Cancer Center (2)  ·  Ohio State University Comprehensive Cancer Center (2)  ·  Rabin Medical Center (2)  ·  University Medical Center Nijmegen (2)  ·  University of Arkansas (1)

Countries

United States (6)  ·  Israel (2)  ·  Netherlands (2)  ·  Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Canada (1)  ·  Germany (1)  ·  Ireland (1)  ·  Italy (1)  ·  Mexico (1)  ·  Norway (1)  ·  Poland (1)  ·  Spain (1)

Top investigators

David Margel, MD, PhD (2)  ·  Elizabeth M. Swisher, MD, PhD (1)  ·  Joanne A de Hullu, MD, PhD (1)  ·  Joanne A. de Hullu, MD, PhD (1)  ·  Karen H. Lu, MD, PhD (1)  ·  Karen M Basen-Engquist (1)  ·  Kent D McKelvey, MD (1)  ·  Leigha Senter, LGC (1)  ·  Nicoline Hoogerbrugge, MD, PhD (1)  ·  Rinat Yerushalmi, MD (1)  ·  Roni Wilke (1)  ·  Rosella PM Hermens, PhD (1)  ·  Steven Clinton, MD (1)

Results publications

PMID 26286255, PMID 31266460, PMID 34081085, PMID 34997316, PMID 36155347, PMID 36946440, PMID 37045546, PMID 37707822, PMID 39509704, PMID 41730824